nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—ESR2—atherosclerosis	0.254	0.619	CbGaD
Ethinyl Estradiol—ESR1—atherosclerosis	0.156	0.381	CbGaD
Ethinyl Estradiol—ABCB11—Rosuvastatin—atherosclerosis	0.073	0.166	CbGbCtD
Ethinyl Estradiol—ABCB11—Pravastatin—atherosclerosis	0.0664	0.151	CbGbCtD
Ethinyl Estradiol—ABCC2—Ezetimibe—atherosclerosis	0.0384	0.0873	CbGbCtD
Ethinyl Estradiol—ABCC2—Simvastatin—atherosclerosis	0.0357	0.0812	CbGbCtD
Ethinyl Estradiol—ABCC2—Pravastatin—atherosclerosis	0.0349	0.0795	CbGbCtD
Ethinyl Estradiol—ABCC2—Lovastatin—atherosclerosis	0.0349	0.0795	CbGbCtD
Ethinyl Estradiol—CYP2B6—Simvastatin—atherosclerosis	0.0227	0.0516	CbGbCtD
Ethinyl Estradiol—CYP2C8—Simvastatin—atherosclerosis	0.0172	0.0391	CbGbCtD
Ethinyl Estradiol—CYP2C8—Lovastatin—atherosclerosis	0.0168	0.0383	CbGbCtD
Ethinyl Estradiol—CYP2C8—Pravastatin—atherosclerosis	0.0168	0.0383	CbGbCtD
Ethinyl Estradiol—ABCB1—Ezetimibe—atherosclerosis	0.0125	0.0285	CbGbCtD
Ethinyl Estradiol—ABCB1—Simvastatin—atherosclerosis	0.0116	0.0265	CbGbCtD
Ethinyl Estradiol—ABCB1—Pravastatin—atherosclerosis	0.0114	0.0259	CbGbCtD
Ethinyl Estradiol—ABCB1—Lovastatin—atherosclerosis	0.0114	0.0259	CbGbCtD
Ethinyl Estradiol—CYP3A4—Rosuvastatin—atherosclerosis	0.00749	0.0171	CbGbCtD
Ethinyl Estradiol—CYP3A4—Ezetimibe—atherosclerosis	0.00749	0.0171	CbGbCtD
Ethinyl Estradiol—CYP3A4—Simvastatin—atherosclerosis	0.00697	0.0159	CbGbCtD
Ethinyl Estradiol—CYP3A4—Lovastatin—atherosclerosis	0.00682	0.0155	CbGbCtD
Ethinyl Estradiol—CYP3A4—Pravastatin—atherosclerosis	0.00682	0.0155	CbGbCtD
Ethinyl Estradiol—Loss of libido—Lovastatin—atherosclerosis	0.00165	0.0232	CcSEcCtD
Ethinyl Estradiol—Loss of libido—Simvastatin—atherosclerosis	0.00154	0.0217	CcSEcCtD
Ethinyl Estradiol—Loss of libido—Pravastatin—atherosclerosis	0.00139	0.0196	CcSEcCtD
Ethinyl Estradiol—SHBG—hindlimb—atherosclerosis	0.00113	0.197	CbGeAlD
Ethinyl Estradiol—Enlargement abdomen—Niacin—atherosclerosis	0.00109	0.0153	CcSEcCtD
Ethinyl Estradiol—Libido increased—Niacin—atherosclerosis	0.00107	0.0151	CcSEcCtD
Ethinyl Estradiol—Breast pain—Niacin—atherosclerosis	0.000749	0.0105	CcSEcCtD
Ethinyl Estradiol—Vaginal inflammation—Niacin—atherosclerosis	0.000653	0.00918	CcSEcCtD
Ethinyl Estradiol—Fluid retention—Niacin—atherosclerosis	0.00062	0.00872	CcSEcCtD
Ethinyl Estradiol—Vaginal infection—Niacin—atherosclerosis	0.000617	0.00867	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Rosuvastatin—atherosclerosis	0.000589	0.00827	CcSEcCtD
Ethinyl Estradiol—Hot flush—Ezetimibe—atherosclerosis	0.000579	0.00814	CcSEcCtD
Ethinyl Estradiol—Eczema—Simvastatin—atherosclerosis	0.000575	0.00808	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Ezetimibe—atherosclerosis	0.000574	0.00807	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Lovastatin—atherosclerosis	0.000552	0.00776	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Ezetimibe—atherosclerosis	0.000541	0.00761	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Rosuvastatin—atherosclerosis	0.000541	0.00761	CcSEcCtD
Ethinyl Estradiol—Eczema—Niacin—atherosclerosis	0.000528	0.00742	CcSEcCtD
Ethinyl Estradiol—Depression—Rosuvastatin—atherosclerosis	0.000501	0.00704	CcSEcCtD
Ethinyl Estradiol—Hot flush—Pravastatin—atherosclerosis	0.000499	0.00701	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Pravastatin—atherosclerosis	0.000495	0.00695	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.000492	0.00692	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Ezetimibe—atherosclerosis	0.000489	0.00688	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Rosuvastatin—atherosclerosis	0.000488	0.00686	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Rosuvastatin—atherosclerosis	0.000471	0.00662	CcSEcCtD
Ethinyl Estradiol—Disturbance in sexual arousal—Niacin—atherosclerosis	0.00047	0.00661	CcSEcCtD
Ethinyl Estradiol—Migraine—Niacin—atherosclerosis	0.000467	0.00656	CcSEcCtD
Ethinyl Estradiol—NR1I2—liver—atherosclerosis	0.000461	0.0798	CbGeAlD
Ethinyl Estradiol—Affect lability—Pravastatin—atherosclerosis	0.000459	0.00646	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Rosuvastatin—atherosclerosis	0.000452	0.00635	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Rosuvastatin—atherosclerosis	0.000447	0.00629	CcSEcCtD
Ethinyl Estradiol—Mood swings—Pravastatin—atherosclerosis	0.000442	0.00622	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000435	0.00611	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Simvastatin—atherosclerosis	0.000429	0.00603	CcSEcCtD
Ethinyl Estradiol—Infestation—Ezetimibe—atherosclerosis	0.000417	0.00587	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Ezetimibe—atherosclerosis	0.000417	0.00587	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000417	0.00586	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000415	0.00583	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Lovastatin—atherosclerosis	0.000414	0.00581	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Niacin—atherosclerosis	0.000413	0.0058	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000409	0.00575	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Pravastatin—atherosclerosis	0.000406	0.00571	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Lovastatin—atherosclerosis	0.000399	0.00561	CcSEcCtD
Ethinyl Estradiol—Depression—Simvastatin—atherosclerosis	0.000397	0.00558	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Rosuvastatin—atherosclerosis	0.000395	0.00555	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Niacin—atherosclerosis	0.000394	0.00554	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Ezetimibe—atherosclerosis	0.000391	0.0055	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00039	0.00548	CcSEcCtD
Ethinyl Estradiol—ESR1—blood vessel—atherosclerosis	0.000382	0.0662	CbGeAlD
Ethinyl Estradiol—Dysuria—Pravastatin—atherosclerosis	0.000377	0.0053	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000375	0.00527	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Simvastatin—atherosclerosis	0.000373	0.00525	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Ezetimibe—atherosclerosis	0.000372	0.00523	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000368	0.00517	CcSEcCtD
Ethinyl Estradiol—Weight increased—Pravastatin—atherosclerosis	0.000367	0.00516	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Pravastatin—atherosclerosis	0.000365	0.00513	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Lovastatin—atherosclerosis	0.000361	0.00508	CcSEcCtD
Ethinyl Estradiol—Estriol—ESR2—atherosclerosis	0.000359	0.0847	CrCbGaD
Ethinyl Estradiol—Depression—Pravastatin—atherosclerosis	0.000359	0.00504	CcSEcCtD
Ethinyl Estradiol—Angioedema—Rosuvastatin—atherosclerosis	0.000358	0.00504	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000355	0.00499	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Ezetimibe—atherosclerosis	0.000354	0.00498	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Pravastatin—atherosclerosis	0.000353	0.00496	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000353	0.00496	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Pravastatin—atherosclerosis	0.00035	0.00492	CcSEcCtD
Ethinyl Estradiol—Cough—Rosuvastatin—atherosclerosis	0.000342	0.00481	CcSEcCtD
Ethinyl Estradiol—Danazol—CCL2—atherosclerosis	0.00034	0.0801	CrCbGaD
Ethinyl Estradiol—Angiopathy—Ezetimibe—atherosclerosis	0.00034	0.00478	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Ezetimibe—atherosclerosis	0.000338	0.00476	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Simvastatin—atherosclerosis	0.000338	0.00475	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Pravastatin—atherosclerosis	0.000338	0.00474	CcSEcCtD
Ethinyl Estradiol—Alopecia—Lovastatin—atherosclerosis	0.000337	0.00474	CcSEcCtD
Ethinyl Estradiol—Quinestrol—ESR1—atherosclerosis	0.000335	0.0789	CrCbGaD
Ethinyl Estradiol—Estramustine—ESR2—atherosclerosis	0.000334	0.0787	CrCbGaD
Ethinyl Estradiol—Alopecia—Ezetimibe—atherosclerosis	0.000331	0.00465	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Niacin—atherosclerosis	0.00033	0.00463	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Niacin—atherosclerosis	0.000329	0.00462	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Ezetimibe—atherosclerosis	0.000328	0.00461	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Niacin—atherosclerosis	0.000328	0.00461	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Niacin—atherosclerosis	0.000326	0.00459	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Ezetimibe—atherosclerosis	0.000326	0.00458	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Pravastatin—atherosclerosis	0.000324	0.00455	CcSEcCtD
Ethinyl Estradiol—Back pain—Lovastatin—atherosclerosis	0.000322	0.00452	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Pravastatin—atherosclerosis	0.000321	0.00452	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Pravastatin—atherosclerosis	0.000321	0.00451	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Lovastatin—atherosclerosis	0.00032	0.00449	CcSEcCtD
Ethinyl Estradiol—Infection—Rosuvastatin—atherosclerosis	0.000318	0.00447	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Niacin—atherosclerosis	0.000316	0.00444	CcSEcCtD
Ethinyl Estradiol—Alopecia—Simvastatin—atherosclerosis	0.000316	0.00444	CcSEcCtD
Ethinyl Estradiol—Back pain—Ezetimibe—atherosclerosis	0.000315	0.00443	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000314	0.00441	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Ezetimibe—atherosclerosis	0.000313	0.00441	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Simvastatin—atherosclerosis	0.000313	0.0044	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Pravastatin—atherosclerosis	0.000311	0.00437	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Lovastatin—atherosclerosis	0.000308	0.00434	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Niacin—atherosclerosis	0.000307	0.00431	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Pravastatin—atherosclerosis	0.000305	0.00429	CcSEcCtD
Ethinyl Estradiol—Angioedema—Lovastatin—atherosclerosis	0.000304	0.00427	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000303	0.00425	CcSEcCtD
Ethinyl Estradiol—Malaise—Lovastatin—atherosclerosis	0.0003	0.00421	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Simvastatin—atherosclerosis	0.000299	0.0042	CcSEcCtD
Ethinyl Estradiol—Angioedema—Ezetimibe—atherosclerosis	0.000298	0.00419	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Niacin—atherosclerosis	0.000298	0.00418	CcSEcCtD
Ethinyl Estradiol—Malaise—Ezetimibe—atherosclerosis	0.000294	0.00413	CcSEcCtD
Ethinyl Estradiol—Alopecia—Niacin—atherosclerosis	0.00029	0.00407	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Simvastatin—atherosclerosis	0.000289	0.00406	CcSEcCtD
Ethinyl Estradiol—ESR2—connective tissue—atherosclerosis	0.000286	0.0495	CbGeAlD
Ethinyl Estradiol—Malnutrition—Niacin—atherosclerosis	0.000286	0.00401	CcSEcCtD
Ethinyl Estradiol—Alopecia—Pravastatin—atherosclerosis	0.000285	0.00401	CcSEcCtD
Ethinyl Estradiol—Cough—Ezetimibe—atherosclerosis	0.000285	0.004	CcSEcCtD
Ethinyl Estradiol—Angioedema—Simvastatin—atherosclerosis	0.000284	0.00399	CcSEcCtD
Ethinyl Estradiol—Anxiety—Lovastatin—atherosclerosis	0.000282	0.00396	CcSEcCtD
Ethinyl Estradiol—Malaise—Simvastatin—atherosclerosis	0.00028	0.00394	CcSEcCtD
Ethinyl Estradiol—Discomfort—Lovastatin—atherosclerosis	0.00028	0.00393	CcSEcCtD
Ethinyl Estradiol—SHBG—connective tissue—atherosclerosis	0.000278	0.0481	CbGeAlD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000276	0.00388	CcSEcCtD
Ethinyl Estradiol—Estropipate—ESR2—atherosclerosis	0.000275	0.0647	CrCbGaD
Ethinyl Estradiol—Muscle spasms—Niacin—atherosclerosis	0.000275	0.00386	CcSEcCtD
Ethinyl Estradiol—Discomfort—Ezetimibe—atherosclerosis	0.000274	0.00386	CcSEcCtD
Ethinyl Estradiol—Constipation—Rosuvastatin—atherosclerosis	0.000274	0.00385	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Pravastatin—atherosclerosis	0.00027	0.0038	CcSEcCtD
Ethinyl Estradiol—Infection—Lovastatin—atherosclerosis	0.00027	0.00379	CcSEcCtD
Ethinyl Estradiol—Infection—Ezetimibe—atherosclerosis	0.000264	0.00372	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000264	0.00371	CcSEcCtD
Ethinyl Estradiol—Anxiety—Simvastatin—atherosclerosis	0.000264	0.00371	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000262	0.00368	CcSEcCtD
Ethinyl Estradiol—Discomfort—Simvastatin—atherosclerosis	0.000262	0.00368	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Ezetimibe—atherosclerosis	0.000261	0.00367	CcSEcCtD
Ethinyl Estradiol—Angioedema—Niacin—atherosclerosis	0.000261	0.00367	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Pravastatin—atherosclerosis	0.000261	0.00367	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Ezetimibe—atherosclerosis	0.000258	0.00363	CcSEcCtD
Ethinyl Estradiol—Angioedema—Pravastatin—atherosclerosis	0.000257	0.00361	CcSEcCtD
Ethinyl Estradiol—Urticaria—Rosuvastatin—atherosclerosis	0.000254	0.00358	CcSEcCtD
Ethinyl Estradiol—Mestranol—ESR1—atherosclerosis	0.000254	0.0598	CrCbGaD
Ethinyl Estradiol—Oedema—Simvastatin—atherosclerosis	0.000254	0.00357	CcSEcCtD
Ethinyl Estradiol—Malaise—Pravastatin—atherosclerosis	0.000254	0.00356	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Rosuvastatin—atherosclerosis	0.000253	0.00356	CcSEcCtD
Ethinyl Estradiol—Infection—Simvastatin—atherosclerosis	0.000252	0.00354	CcSEcCtD
Ethinyl Estradiol—Desogestrel—ESR1—atherosclerosis	0.000251	0.0591	CrCbGaD
Ethinyl Estradiol—Cough—Niacin—atherosclerosis	0.000249	0.0035	CcSEcCtD
Ethinyl Estradiol—ESR2—cardiovascular system—atherosclerosis	0.000249	0.0431	CbGeAlD
Ethinyl Estradiol—Cough—Pravastatin—atherosclerosis	0.000245	0.00345	CcSEcCtD
Ethinyl Estradiol—SHBG—cardiovascular system—atherosclerosis	0.000242	0.0419	CbGeAlD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000241	0.00339	CcSEcCtD
Ethinyl Estradiol—Anxiety—Pravastatin—atherosclerosis	0.000239	0.00335	CcSEcCtD
Ethinyl Estradiol—Discomfort—Pravastatin—atherosclerosis	0.000236	0.00332	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000236	0.00332	CcSEcCtD
Ethinyl Estradiol—Fatigue—Lovastatin—atherosclerosis	0.000234	0.00329	CcSEcCtD
Ethinyl Estradiol—Oedema—Niacin—atherosclerosis	0.000233	0.00328	CcSEcCtD
Ethinyl Estradiol—Constipation—Lovastatin—atherosclerosis	0.000232	0.00326	CcSEcCtD
Ethinyl Estradiol—SLC10A1—liver—atherosclerosis	0.00023	0.0399	CbGeAlD
Ethinyl Estradiol—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00023	0.00323	CcSEcCtD
Ethinyl Estradiol—Asthenia—Rosuvastatin—atherosclerosis	0.00023	0.00323	CcSEcCtD
Ethinyl Estradiol—Oedema—Pravastatin—atherosclerosis	0.000229	0.00323	CcSEcCtD
Ethinyl Estradiol—Fatigue—Ezetimibe—atherosclerosis	0.000229	0.00323	CcSEcCtD
Ethinyl Estradiol—Infection—Pravastatin—atherosclerosis	0.000228	0.0032	CcSEcCtD
Ethinyl Estradiol—Constipation—Ezetimibe—atherosclerosis	0.000228	0.0032	CcSEcCtD
Ethinyl Estradiol—ABCB11—liver—atherosclerosis	0.000227	0.0394	CbGeAlD
Ethinyl Estradiol—Pruritus—Rosuvastatin—atherosclerosis	0.000227	0.00318	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Niacin—atherosclerosis	0.000226	0.00318	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Lovastatin—atherosclerosis	0.000224	0.00314	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000222	0.00312	CcSEcCtD
Ethinyl Estradiol—Estriol—ESR1—atherosclerosis	0.000221	0.0522	CrCbGaD
Ethinyl Estradiol—Feeling abnormal—Ezetimibe—atherosclerosis	0.000219	0.00308	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000219	0.00308	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Rosuvastatin—atherosclerosis	0.000219	0.00308	CcSEcCtD
Ethinyl Estradiol—Fatigue—Simvastatin—atherosclerosis	0.000219	0.00308	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000218	0.00306	CcSEcCtD
Ethinyl Estradiol—Constipation—Simvastatin—atherosclerosis	0.000217	0.00305	CcSEcCtD
Ethinyl Estradiol—Urticaria—Lovastatin—atherosclerosis	0.000216	0.00303	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Lovastatin—atherosclerosis	0.000214	0.00301	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Lovastatin—atherosclerosis	0.000214	0.00301	CcSEcCtD
Ethinyl Estradiol—SHBG—adipose tissue—atherosclerosis	0.000213	0.0369	CbGeAlD
Ethinyl Estradiol—Dizziness—Rosuvastatin—atherosclerosis	0.000212	0.00298	CcSEcCtD
Ethinyl Estradiol—Urticaria—Ezetimibe—atherosclerosis	0.000211	0.00297	CcSEcCtD
Ethinyl Estradiol—AOX1—adipose tissue—atherosclerosis	0.000211	0.0366	CbGeAlD
Ethinyl Estradiol—Abdominal pain—Ezetimibe—atherosclerosis	0.00021	0.00296	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Ezetimibe—atherosclerosis	0.00021	0.00296	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Simvastatin—atherosclerosis	0.000209	0.00294	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000208	0.00292	CcSEcCtD
Ethinyl Estradiol—Estramustine—ESR1—atherosclerosis	0.000206	0.0485	CrCbGaD
Ethinyl Estradiol—Etonogestrel—ESR1—atherosclerosis	0.000203	0.0478	CrCbGaD
Ethinyl Estradiol—Rash—Rosuvastatin—atherosclerosis	0.000202	0.00284	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Rosuvastatin—atherosclerosis	0.000202	0.00283	CcSEcCtD
Ethinyl Estradiol—Urticaria—Simvastatin—atherosclerosis	0.000202	0.00283	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Niacin—atherosclerosis	0.000201	0.00283	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Simvastatin—atherosclerosis	0.000201	0.00282	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Simvastatin—atherosclerosis	0.000201	0.00282	CcSEcCtD
Ethinyl Estradiol—Headache—Rosuvastatin—atherosclerosis	0.000201	0.00282	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Lovastatin—atherosclerosis	0.0002	0.00281	CcSEcCtD
Ethinyl Estradiol—Fatigue—Pravastatin—atherosclerosis	0.000198	0.00278	CcSEcCtD
Ethinyl Estradiol—Constipation—Pravastatin—atherosclerosis	0.000196	0.00276	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Ezetimibe—atherosclerosis	0.000196	0.00276	CcSEcCtD
Ethinyl Estradiol—ESR1—connective tissue—atherosclerosis	0.000196	0.0339	CbGeAlD
Ethinyl Estradiol—Asthenia—Lovastatin—atherosclerosis	0.000195	0.00274	CcSEcCtD
Ethinyl Estradiol—Pruritus—Lovastatin—atherosclerosis	0.000192	0.0027	CcSEcCtD
Ethinyl Estradiol—Asthenia—Ezetimibe—atherosclerosis	0.000191	0.00268	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Niacin—atherosclerosis	0.000191	0.00268	CcSEcCtD
Ethinyl Estradiol—Nausea—Rosuvastatin—atherosclerosis	0.00019	0.00267	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Pravastatin—atherosclerosis	0.000189	0.00266	CcSEcCtD
Ethinyl Estradiol—Pruritus—Ezetimibe—atherosclerosis	0.000188	0.00265	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000188	0.00264	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Simvastatin—atherosclerosis	0.000187	0.00263	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Lovastatin—atherosclerosis	0.000186	0.00261	CcSEcCtD
Ethinyl Estradiol—Urticaria—Niacin—atherosclerosis	0.000185	0.0026	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Niacin—atherosclerosis	0.000184	0.00259	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Niacin—atherosclerosis	0.000184	0.00259	CcSEcCtD
Ethinyl Estradiol—Urticaria—Pravastatin—atherosclerosis	0.000182	0.00256	CcSEcCtD
Ethinyl Estradiol—Asthenia—Simvastatin—atherosclerosis	0.000182	0.00256	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Ezetimibe—atherosclerosis	0.000182	0.00256	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Pravastatin—atherosclerosis	0.000181	0.00255	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Pravastatin—atherosclerosis	0.000181	0.00255	CcSEcCtD
Ethinyl Estradiol—Pruritus—Simvastatin—atherosclerosis	0.00018	0.00252	CcSEcCtD
Ethinyl Estradiol—Dizziness—Lovastatin—atherosclerosis	0.000179	0.00252	CcSEcCtD
Ethinyl Estradiol—Dizziness—Ezetimibe—atherosclerosis	0.000176	0.00247	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Simvastatin—atherosclerosis	0.000174	0.00244	CcSEcCtD
Ethinyl Estradiol—Vomiting—Lovastatin—atherosclerosis	0.000173	0.00242	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Niacin—atherosclerosis	0.000172	0.00241	CcSEcCtD
Ethinyl Estradiol—Conjugated Estrogens—ESR2—atherosclerosis	0.000172	0.0404	CrCbGaD
Ethinyl Estradiol—Estrone—ESR2—atherosclerosis	0.000171	0.0403	CrCbGaD
Ethinyl Estradiol—Rash—Lovastatin—atherosclerosis	0.000171	0.0024	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Lovastatin—atherosclerosis	0.000171	0.0024	CcSEcCtD
Ethinyl Estradiol—ESR1—cardiovascular system—atherosclerosis	0.00017	0.0295	CbGeAlD
Ethinyl Estradiol—Headache—Lovastatin—atherosclerosis	0.00017	0.00239	CcSEcCtD
Ethinyl Estradiol—Estropipate—ESR1—atherosclerosis	0.000169	0.0399	CrCbGaD
Ethinyl Estradiol—Vomiting—Ezetimibe—atherosclerosis	0.000169	0.00238	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Pravastatin—atherosclerosis	0.000169	0.00238	CcSEcCtD
Ethinyl Estradiol—Dizziness—Simvastatin—atherosclerosis	0.000168	0.00236	CcSEcCtD
Ethinyl Estradiol—Rash—Ezetimibe—atherosclerosis	0.000168	0.00236	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Ezetimibe—atherosclerosis	0.000168	0.00236	CcSEcCtD
Ethinyl Estradiol—Asthenia—Niacin—atherosclerosis	0.000167	0.00235	CcSEcCtD
Ethinyl Estradiol—Headache—Ezetimibe—atherosclerosis	0.000167	0.00234	CcSEcCtD
Ethinyl Estradiol—Pruritus—Niacin—atherosclerosis	0.000165	0.00232	CcSEcCtD
Ethinyl Estradiol—Asthenia—Pravastatin—atherosclerosis	0.000165	0.00231	CcSEcCtD
Ethinyl Estradiol—Pruritus—Pravastatin—atherosclerosis	0.000162	0.00228	CcSEcCtD
Ethinyl Estradiol—Vomiting—Simvastatin—atherosclerosis	0.000161	0.00227	CcSEcCtD
Ethinyl Estradiol—Nausea—Lovastatin—atherosclerosis	0.000161	0.00227	CcSEcCtD
Ethinyl Estradiol—Rash—Simvastatin—atherosclerosis	0.00016	0.00225	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Simvastatin—atherosclerosis	0.00016	0.00225	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Niacin—atherosclerosis	0.000159	0.00224	CcSEcCtD
Ethinyl Estradiol—Headache—Simvastatin—atherosclerosis	0.000159	0.00223	CcSEcCtD
Ethinyl Estradiol—Nausea—Ezetimibe—atherosclerosis	0.000158	0.00222	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Pravastatin—atherosclerosis	0.000157	0.00221	CcSEcCtD
Ethinyl Estradiol—Dizziness—Niacin—atherosclerosis	0.000154	0.00217	CcSEcCtD
Ethinyl Estradiol—ESR2—liver—atherosclerosis	0.000154	0.0266	CbGeAlD
Ethinyl Estradiol—Dizziness—Pravastatin—atherosclerosis	0.000152	0.00213	CcSEcCtD
Ethinyl Estradiol—ABCB1—blood vessel—atherosclerosis	0.000151	0.0261	CbGeAlD
Ethinyl Estradiol—Nausea—Simvastatin—atherosclerosis	0.000151	0.00212	CcSEcCtD
Ethinyl Estradiol—ESR1—adipose tissue—atherosclerosis	0.00015	0.026	CbGeAlD
Ethinyl Estradiol—SHBG—liver—atherosclerosis	0.000149	0.0259	CbGeAlD
Ethinyl Estradiol—Vomiting—Niacin—atherosclerosis	0.000148	0.00208	CcSEcCtD
Ethinyl Estradiol—AOX1—liver—atherosclerosis	0.000148	0.0257	CbGeAlD
Ethinyl Estradiol—Rash—Niacin—atherosclerosis	0.000147	0.00207	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Niacin—atherosclerosis	0.000147	0.00206	CcSEcCtD
Ethinyl Estradiol—Headache—Niacin—atherosclerosis	0.000146	0.00205	CcSEcCtD
Ethinyl Estradiol—Vomiting—Pravastatin—atherosclerosis	0.000146	0.00205	CcSEcCtD
Ethinyl Estradiol—Rash—Pravastatin—atherosclerosis	0.000145	0.00203	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Pravastatin—atherosclerosis	0.000145	0.00203	CcSEcCtD
Ethinyl Estradiol—Headache—Pravastatin—atherosclerosis	0.000144	0.00202	CcSEcCtD
Ethinyl Estradiol—Levonorgestrel—ESR1—atherosclerosis	0.000144	0.0338	CrCbGaD
Ethinyl Estradiol—Nausea—Niacin—atherosclerosis	0.000138	0.00195	CcSEcCtD
Ethinyl Estradiol—Nausea—Pravastatin—atherosclerosis	0.000136	0.00192	CcSEcCtD
Ethinyl Estradiol—Danazol—ESR1—atherosclerosis	0.000131	0.0308	CrCbGaD
Ethinyl Estradiol—Estradiol—ESR2—atherosclerosis	0.00013	0.0305	CrCbGaD
Ethinyl Estradiol—CYP2B6—cardiovascular system—atherosclerosis	0.000126	0.0218	CbGeAlD
Ethinyl Estradiol—ABCC2—liver—atherosclerosis	0.000116	0.02	CbGeAlD
Ethinyl Estradiol—Conjugated Estrogens—ESR1—atherosclerosis	0.000106	0.0249	CrCbGaD
Ethinyl Estradiol—Estrone—ESR1—atherosclerosis	0.000105	0.0248	CrCbGaD
Ethinyl Estradiol—ESR1—liver—atherosclerosis	0.000105	0.0183	CbGeAlD
Ethinyl Estradiol—CYP2C8—liver—atherosclerosis	8.67e-05	0.015	CbGeAlD
Ethinyl Estradiol—Estradiol—ESR1—atherosclerosis	7.99e-05	0.0188	CrCbGaD
Ethinyl Estradiol—CYP2B6—liver—atherosclerosis	7.78e-05	0.0135	CbGeAlD
Ethinyl Estradiol—Estropipate—ALB—atherosclerosis	7.54e-05	0.0178	CrCbGaD
Ethinyl Estradiol—ABCB1—cardiovascular system—atherosclerosis	6.73e-05	0.0117	CbGeAlD
Ethinyl Estradiol—ABCB1—adipose tissue—atherosclerosis	5.93e-05	0.0103	CbGeAlD
Ethinyl Estradiol—CYP3A4—liver—atherosclerosis	5.88e-05	0.0102	CbGeAlD
Ethinyl Estradiol—Norethindrone—ALB—atherosclerosis	5.18e-05	0.0122	CrCbGaD
Ethinyl Estradiol—Methyltestosterone—ALB—atherosclerosis	4.92e-05	0.0116	CrCbGaD
Ethinyl Estradiol—Estrone—ALB—atherosclerosis	4.69e-05	0.0111	CrCbGaD
Ethinyl Estradiol—ABCB1—liver—atherosclerosis	4.16e-05	0.00721	CbGeAlD
Ethinyl Estradiol—Estradiol—ALB—atherosclerosis	3.56e-05	0.00838	CrCbGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—APOC3—atherosclerosis	9.55e-06	0.000137	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—NOS3—atherosclerosis	9.52e-06	0.000136	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—LCAT—atherosclerosis	9.5e-06	0.000136	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—FABP4—atherosclerosis	9.5e-06	0.000136	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—LDLR—atherosclerosis	9.49e-06	0.000136	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	9.39e-06	0.000135	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—MTHFR—atherosclerosis	9.35e-06	0.000134	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	9.33e-06	0.000134	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—APOA4—atherosclerosis	9.32e-06	0.000134	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCL3—atherosclerosis	9.27e-06	0.000133	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ALOX5—atherosclerosis	9.25e-06	0.000133	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	9.21e-06	0.000132	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—APOA2—atherosclerosis	9.21e-06	0.000132	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ALOX15—atherosclerosis	9.21e-06	0.000132	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	9.21e-06	0.000132	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PPARA—atherosclerosis	9.17e-06	0.000131	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP7A1—atherosclerosis	9.16e-06	0.000131	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ABCG5—atherosclerosis	9.1e-06	0.00013	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	9.09e-06	0.00013	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PLTP—atherosclerosis	9.08e-06	0.00013	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	9.03e-06	0.000129	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—AGT—atherosclerosis	8.88e-06	0.000127	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NCF1—atherosclerosis	8.88e-06	0.000127	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—LPA—atherosclerosis	8.79e-06	0.000126	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—APOE—atherosclerosis	8.7e-06	0.000125	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PTGS2—atherosclerosis	8.7e-06	0.000125	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	8.66e-06	0.000124	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—CAV1—atherosclerosis	8.62e-06	0.000124	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—APOA1—atherosclerosis	8.61e-06	0.000123	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	8.54e-06	0.000122	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—BGN—atherosclerosis	8.51e-06	0.000122	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP27A1—atherosclerosis	8.47e-06	0.000121	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	8.45e-06	0.000121	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—APOA5—atherosclerosis	8.43e-06	0.000121	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCR2—atherosclerosis	8.39e-06	0.00012	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—EDNRA—atherosclerosis	8.39e-06	0.00012	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CYBA—atherosclerosis	8.35e-06	0.00012	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	8.3e-06	0.000119	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—NAMPT—atherosclerosis	8.3e-06	0.000119	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	8.29e-06	0.000119	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—LIPC—atherosclerosis	8.25e-06	0.000118	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—APOC3—atherosclerosis	8.2e-06	0.000117	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	8.18e-06	0.000117	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PARP1—atherosclerosis	8.17e-06	0.000117	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—GHRL—atherosclerosis	8.17e-06	0.000117	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PLAT—atherosclerosis	8.17e-06	0.000117	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—LDLR—atherosclerosis	8.15e-06	0.000117	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	8.11e-06	0.000116	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—STAT3—atherosclerosis	8.1e-06	0.000116	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ALOX5AP—atherosclerosis	8.03e-06	0.000115	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PLA2G2A—atherosclerosis	8.03e-06	0.000115	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ALOX15—atherosclerosis	8.03e-06	0.000115	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—APOA2—atherosclerosis	8.03e-06	0.000115	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	8.02e-06	0.000115	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PPARA—atherosclerosis	7.97e-06	0.000114	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CETP—atherosclerosis	7.96e-06	0.000114	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.94e-06	0.000114	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ABCG5—atherosclerosis	7.93e-06	0.000114	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.93e-06	0.000114	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ABCG8—atherosclerosis	7.87e-06	0.000113	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—LTA4H—atherosclerosis	7.87e-06	0.000113	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PIK3CG—atherosclerosis	7.86e-06	0.000113	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ALOX5—atherosclerosis	7.83e-06	0.000112	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MAPK3—atherosclerosis	7.74e-06	0.000111	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	7.74e-06	0.000111	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—MAPK3—atherosclerosis	7.66e-06	0.00011	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—LPA—atherosclerosis	7.66e-06	0.00011	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—SCARB1—atherosclerosis	7.62e-06	0.000109	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PPARG—atherosclerosis	7.58e-06	0.000109	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—TGFB1—atherosclerosis	7.51e-06	0.000108	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—INS—atherosclerosis	7.44e-06	0.000107	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—BGN—atherosclerosis	7.41e-06	0.000106	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—APOA5—atherosclerosis	7.34e-06	0.000105	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—AKT1—atherosclerosis	7.34e-06	0.000105	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.24e-06	0.000104	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—HMGCR—atherosclerosis	7.19e-06	0.000103	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KNG1—atherosclerosis	7.17e-06	0.000103	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—AGTR1—atherosclerosis	7.13e-06	0.000102	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PLA2G1B—atherosclerosis	7.07e-06	0.000101	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—NAMPT—atherosclerosis	7.03e-06	0.000101	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	7e-06	0.0001	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.98e-06	0.0001	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—LIPC—atherosclerosis	6.98e-06	0.0001	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PLG—atherosclerosis	6.95e-06	9.96e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—APOC3—atherosclerosis	6.94e-06	9.94e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—LDLR—atherosclerosis	6.9e-06	9.88e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ALOX5—atherosclerosis	6.82e-06	9.78e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ALB—atherosclerosis	6.82e-06	9.77e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CETP—atherosclerosis	6.74e-06	9.65e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PPARG—atherosclerosis	6.59e-06	9.44e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SOCS3—atherosclerosis	6.58e-06	9.43e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.57e-06	9.41e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—NOS3—atherosclerosis	6.52e-06	9.35e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—SCARB1—atherosclerosis	6.45e-06	9.24e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ABCA1—atherosclerosis	6.41e-06	9.19e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MMP3—atherosclerosis	6.36e-06	9.11e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IGF2—atherosclerosis	6.33e-06	9.07e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.28e-06	9e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ABCG1—atherosclerosis	6.22e-06	8.92e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—APOB—atherosclerosis	6.14e-06	8.8e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—NAMPT—atherosclerosis	6.12e-06	8.77e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—HMGCR—atherosclerosis	6.09e-06	8.73e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—LIPC—atherosclerosis	6.08e-06	8.72e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—EDN1—atherosclerosis	6.05e-06	8.66e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—APOC3—atherosclerosis	6.04e-06	8.66e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—LDLR—atherosclerosis	6.01e-06	8.61e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCL5—atherosclerosis	6e-06	8.6e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PTGS2—atherosclerosis	5.96e-06	8.55e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—SERPINE1—atherosclerosis	5.93e-06	8.5e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CETP—atherosclerosis	5.87e-06	8.41e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—LPL—atherosclerosis	5.87e-06	8.41e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—FABP4—atherosclerosis	5.85e-06	8.39e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—LCAT—atherosclerosis	5.85e-06	8.39e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	5.76e-06	8.26e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—APOA4—atherosclerosis	5.74e-06	8.23e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PRKCG—atherosclerosis	5.7e-06	8.17e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—IL6—atherosclerosis	5.66e-06	8.11e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP7A1—atherosclerosis	5.64e-06	8.09e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—SCARB1—atherosclerosis	5.62e-06	8.05e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SPP1—atherosclerosis	5.56e-06	7.96e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—HMOX1—atherosclerosis	5.5e-06	7.88e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.49e-06	7.87e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ABCA1—atherosclerosis	5.43e-06	7.78e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—HMGCR—atherosclerosis	5.31e-06	7.6e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—APOB—atherosclerosis	5.27e-06	7.55e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—AKT1—atherosclerosis	5.22e-06	7.48e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP27A1—atherosclerosis	5.22e-06	7.47e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	5.2e-06	7.46e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—AKT1—atherosclerosis	5.16e-06	7.4e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PDGFB—atherosclerosis	5.14e-06	7.37e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GSTM1—atherosclerosis	5.13e-06	7.35e-05	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—AKT1—atherosclerosis	5.09e-06	7.29e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—LPL—atherosclerosis	5.03e-06	7.21e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—AGT—atherosclerosis	5.02e-06	7.19e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ALOX15—atherosclerosis	4.94e-06	7.09e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	4.94e-06	7.09e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	4.94e-06	7.09e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—APOA2—atherosclerosis	4.94e-06	7.09e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—LEP—atherosclerosis	4.92e-06	7.05e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—APOE—atherosclerosis	4.92e-06	7.05e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GPX1—atherosclerosis	4.91e-06	7.04e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ABCG5—atherosclerosis	4.88e-06	7e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CAV1—atherosclerosis	4.87e-06	6.98e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—APOA1—atherosclerosis	4.86e-06	6.97e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CD36—atherosclerosis	4.78e-06	6.85e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ABCA1—atherosclerosis	4.73e-06	6.78e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—LPA—atherosclerosis	4.72e-06	6.76e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—HMOX1—atherosclerosis	4.66e-06	6.68e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—F2—atherosclerosis	4.64e-06	6.64e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—BGN—atherosclerosis	4.57e-06	6.55e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—MTHFR—atherosclerosis	4.53e-06	6.49e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—APOA5—atherosclerosis	4.52e-06	6.48e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—APOB—atherosclerosis	4.46e-06	6.39e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PPARA—atherosclerosis	4.44e-06	6.37e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PIK3CG—atherosclerosis	4.44e-06	6.36e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—AKT1—atherosclerosis	4.37e-06	6.27e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	4.35e-06	6.24e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTM1—atherosclerosis	4.34e-06	6.22e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—AGT—atherosclerosis	4.3e-06	6.17e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—LPL—atherosclerosis	4.26e-06	6.11e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—APOE—atherosclerosis	4.22e-06	6.04e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.2e-06	6.02e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—INS—atherosclerosis	4.2e-06	6.02e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CAV1—atherosclerosis	4.18e-06	5.99e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—APOA1—atherosclerosis	4.17e-06	5.98e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GPX1—atherosclerosis	4.16e-06	5.96e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCL2—atherosclerosis	4.13e-06	5.92e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IGF1—atherosclerosis	4.06e-06	5.82e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—HMOX1—atherosclerosis	4.06e-06	5.82e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CD36—atherosclerosis	4.05e-06	5.8e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—APOB—atherosclerosis	3.89e-06	5.57e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—MAPK3—atherosclerosis	3.86e-06	5.53e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SERPINE1—atherosclerosis	3.86e-06	5.53e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—MTHFR—atherosclerosis	3.84e-06	5.5e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PIK3CG—atherosclerosis	3.81e-06	5.46e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTM1—atherosclerosis	3.78e-06	5.42e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.77e-06	5.4e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PPARA—atherosclerosis	3.76e-06	5.39e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—LIPC—atherosclerosis	3.75e-06	5.37e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—APOC3—atherosclerosis	3.72e-06	5.34e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—LPL—atherosclerosis	3.71e-06	5.32e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—LDLR—atherosclerosis	3.7e-06	5.3e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NOS3—atherosclerosis	3.68e-06	5.28e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PPARG—atherosclerosis	3.67e-06	5.27e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—AGT—atherosclerosis	3.64e-06	5.22e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GPX1—atherosclerosis	3.62e-06	5.19e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CETP—atherosclerosis	3.62e-06	5.18e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—INS—atherosclerosis	3.6e-06	5.16e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—APOE—atherosclerosis	3.57e-06	5.12e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CAV1—atherosclerosis	3.54e-06	5.07e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—APOA1—atherosclerosis	3.53e-06	5.06e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CD36—atherosclerosis	3.53e-06	5.05e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.46e-06	4.96e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—MTHFR—atherosclerosis	3.34e-06	4.79e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ALB—atherosclerosis	3.3e-06	4.73e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PPARA—atherosclerosis	3.28e-06	4.7e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.27e-06	4.69e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CXCL8—atherosclerosis	3.27e-06	4.68e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PIK3CG—atherosclerosis	3.22e-06	4.62e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—AGT—atherosclerosis	3.18e-06	4.55e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—NOS3—atherosclerosis	3.16e-06	4.53e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—APOE—atherosclerosis	3.11e-06	4.46e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PPARG—atherosclerosis	3.11e-06	4.46e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CAV1—atherosclerosis	3.08e-06	4.42e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—APOA1—atherosclerosis	3.08e-06	4.41e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—INS—atherosclerosis	3.05e-06	4.37e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—AKT1—atherosclerosis	3e-06	4.3e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MMP9—atherosclerosis	2.96e-06	4.24e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NFKB1—atherosclerosis	2.92e-06	4.19e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.91e-06	4.18e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PTGS2—atherosclerosis	2.89e-06	4.14e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MAPK8—atherosclerosis	2.87e-06	4.12e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.81e-06	4.02e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ALB—atherosclerosis	2.8e-06	4.01e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PPARG—atherosclerosis	2.71e-06	3.88e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—NOS3—atherosclerosis	2.68e-06	3.83e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—INS—atherosclerosis	2.66e-06	3.81e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—VEGFA—atherosclerosis	2.65e-06	3.8e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—STAT3—atherosclerosis	2.63e-06	3.77e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—AKT1—atherosclerosis	2.6e-06	3.73e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MAPK3—atherosclerosis	2.51e-06	3.6e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.5e-06	3.58e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.45e-06	3.51e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ALB—atherosclerosis	2.44e-06	3.49e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TGFB1—atherosclerosis	2.44e-06	3.49e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—APOB—atherosclerosis	2.39e-06	3.43e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—NOS3—atherosclerosis	2.33e-06	3.34e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.33e-06	3.34e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—LPL—atherosclerosis	2.29e-06	3.28e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GPX1—atherosclerosis	2.23e-06	3.2e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CD36—atherosclerosis	2.17e-06	3.11e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PTGS2—atherosclerosis	2.13e-06	3.05e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.06e-06	2.95e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PPARA—atherosclerosis	2.02e-06	2.89e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—AGT—atherosclerosis	1.96e-06	2.8e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—APOE—atherosclerosis	1.92e-06	2.75e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CAV1—atherosclerosis	1.9e-06	2.72e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—APOA1—atherosclerosis	1.89e-06	2.72e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL6—atherosclerosis	1.84e-06	2.63e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.73e-06	2.48e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—AKT1—atherosclerosis	1.69e-06	2.43e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PPARG—atherosclerosis	1.67e-06	2.39e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—INS—atherosclerosis	1.64e-06	2.35e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ALB—atherosclerosis	1.5e-06	2.15e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—AKT1—atherosclerosis	1.45e-06	2.08e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—NOS3—atherosclerosis	1.44e-06	2.06e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.31e-06	1.88e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—AKT1—atherosclerosis	1.23e-06	1.76e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—AKT1—atherosclerosis	1.07e-06	1.54e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—AKT1—atherosclerosis	6.6e-07	9.46e-06	CbGpPWpGaD
